Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01952249
Title A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

fallopian tube cancer

peritoneum cancer

ovarian cancer

Therapies

Demcizumab

Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.